These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 8609898)
1. Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice. Javitch JA; Fu D; Chen J Mol Pharmacol; 1996 Apr; 49(4):692-8. PubMed ID: 8609898 [TBL] [Abstract][Full Text] [Related]
2. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. Javitch JA; Ballesteros JA; Weinstein H; Chen J Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590 [TBL] [Abstract][Full Text] [Related]
3. A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice. Javitch JA; Li X; Kaback J; Karlin A Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10355-9. PubMed ID: 7937955 [TBL] [Abstract][Full Text] [Related]
4. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. Fu D; Ballesteros JA; Weinstein H; Chen J; Javitch JA Biochemistry; 1996 Sep; 35(35):11278-85. PubMed ID: 8784181 [TBL] [Abstract][Full Text] [Related]
5. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment. Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039 [TBL] [Abstract][Full Text] [Related]
6. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. Javitch JA; Fu D; Chen J Biochemistry; 1995 Dec; 34(50):16433-9. PubMed ID: 8845371 [TBL] [Abstract][Full Text] [Related]
7. Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology. Schetz JA; Benjamin PS; Sibley DR Mol Pharmacol; 2000 Jan; 57(1):144-52. PubMed ID: 10617689 [TBL] [Abstract][Full Text] [Related]
8. MTSEA prevents ligand binding to the human melanocortin-4 receptor by modification of cysteine 130 in transmembrane helix 3. Cox A; Donnelly D; Kaur M; Cheetham SC; Cockcroft VB; Findlay JB FEBS Lett; 2005 Jan; 579(1):285-91. PubMed ID: 15620728 [TBL] [Abstract][Full Text] [Related]
9. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents. Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553 [TBL] [Abstract][Full Text] [Related]
11. Probing the agonist domain of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis reveals residues in proximity to the alpha-bungarotoxin binding site. Spura A; Russin TS; Freedman ND; Grant M; McLaughlin JT; Hawrot E Biochemistry; 1999 Apr; 38(16):4912-21. PubMed ID: 10213592 [TBL] [Abstract][Full Text] [Related]
12. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773 [TBL] [Abstract][Full Text] [Related]
13. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor. Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168 [TBL] [Abstract][Full Text] [Related]
15. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method. Javitch JA; Fu D; Chen J; Karlin A Neuron; 1995 Apr; 14(4):825-31. PubMed ID: 7718244 [TBL] [Abstract][Full Text] [Related]
16. Cysteine-scanning mutagenesis and thiol modification of the Rickettsia prowazekii ATP/ADP translocase: evidence that TM VIII faces an aqueous channel. Winkler HH; Daugherty RM; Audia JP Biochemistry; 2003 Nov; 42(43):12562-9. PubMed ID: 14580202 [TBL] [Abstract][Full Text] [Related]
17. Identification of a Zn2+-binding site on the dopamine D2 receptor. Liu Y; Teeter MM; DuRand CJ; Neve KA Biochem Biophys Res Commun; 2006 Jan; 339(3):873-9. PubMed ID: 16332354 [TBL] [Abstract][Full Text] [Related]
18. Evidence for the proximity of the extreme N-terminus of the neurokinin-2 (NK2) tachykinin receptor to Cys167 in the putative fourth transmembrane helix. Bhogal N; Blaney FE; Ingley PM; Rees J; Findlay JB Biochemistry; 2004 Mar; 43(11):3027-38. PubMed ID: 15023054 [TBL] [Abstract][Full Text] [Related]
19. Identification of acetylcholine receptor channel-lining residues in the M1 segment of the beta-subunit. Zhang H; Karlin A Biochemistry; 1997 Dec; 36(50):15856-64. PubMed ID: 9398318 [TBL] [Abstract][Full Text] [Related]
20. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding. Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]